Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2−/− Mice

• M. Ujue Latasa ,

  Contributed equally to this work with: M. Ujue Latasa, Carmen Gil-Puig

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• Carmen Gil-Puig ,

  Contributed equally to this work with: M. Ujue Latasa, Carmen Gil-Puig

  Affiliations Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain, Digna Biotech, Madrid, Spain

  ⨯
• Maite G. Fernández-Barrena,

  Affiliations Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain, CIBERehd, University Clinic, University of Navarra, Pamplona, Spain

  ⨯
• Carlos M. Rodríguez-Ortigosa,

  Affiliations Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain, CIBERehd, University Clinic, University of Navarra, Pamplona, Spain

  ⨯
• Jesús M. Banales,

  Affiliations Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain, CIBERehd, University Clinic, University of Navarra, Pamplona, Spain

  ⨯
• Raquel Urtasun,

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• Saioa Goñi,

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• Miriam Méndez,

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• Sara Arcelus,

  Affiliation CIBERehd, University Clinic, University of Navarra, Pamplona, Spain

  ⨯
• Nerea Juanarena,

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• Juan A. Recio,

  Affiliation Vall d'Hebron Research Institute, Institute of Oncology and Hospital, Barcelona, Spain

  ⨯
• Sophie Lotersztajn,

  Affiliations Inserm, U955, Créteil, France, Université Paris-Est, Faculté de Médecine, UMR-S955, Créteil, France

  ⨯
• Jesús Prieto,

  Affiliations Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain, CIBERehd, University Clinic, University of Navarra, Pamplona, Spain

  ⨯
• Carmen Berasain,

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• Fernando J. Corrales,

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• Jon Lecanda ,

  ¶These authors also contributed equally to this work.

  Affiliations Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain, Digna Biotech, Madrid, Spain

  ⨯
•  [ ... ],
• Matías A. Ávila

  * E-mail: maavila@unav.es

  ¶These authors also contributed equally to this work.

  Affiliation Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

  ⨯
• [ view all ]
• [ view less ]